Inventor

LIU SHIFENG

CN44 patents

⚠️ This page may combine multiple inventors who share the name “LIU SHIFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIU SHIFENG

XENON PHARMACEUTICALS INC

Pyridazine derivatives and their use as therapeutic agents

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

Spiro-oxindole compounds and their uses as therapeutic agents

Spiroheterocyclic compounds and their uses as therapeutic agents

Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

Spiro-oxindole compounds and their uses as therapeutic agents

Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

Pyridazine derivatives and their use as therapeutic agents

Piperazine derivatives and their use as therapeutic agents

Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

Spiro-oxindole compounds and their use as therapeutic agents

Combination therapy

Heterocyclic derivatives and their use as therapeutic agents

Biaryl ether sulfonamides and their use as therapeutic agents

Pyridyl derivatives and their use as therapeutic agents

Pyridazine derivatives and their use as therapeutic agents

Spiro-oxindole compounds and their use as therapeutic agents

Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

Pyridyl derivatives and their use as therapeutic agents

Pyridyl derivatives and their use as therapeutic agents

Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

HANGZHOU INNOGATE PHARMA CO LTD

Heterocyclic compound serving as FGFR4 inhibitor

Heterocycles useful as anti-cancer agents

Compound containing tricyclic heteroaryl group

Compound containing tricyclic heteroaryl group

Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor

Heterocyclic compound used as FGFR inhibitor

Heterocycles useful as IDO and TDO inhibitors

CHAFEEV MIKHAIL

Use of spiro-oxindole compounds as therapeutic agents

Spiro-oxindole compounds and their uses as therapeutic agents

Spiro-oxindole compounds and their use as therapeutic agents

Spiro-oxindole compounds and their use as therapeutic agents

Spiro-oxindole compounds and their uses as therapeutic agents

DALES NATALIE

Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels

Organic compounds

XIAMEN BIOTIME BIOTECHNOLOGY CO LTD

Adenosine receptor antagonist

Highly active CSF1R inhibitor compound

GUANGDONG SHUNDE COCO WHEAT TECH INDUSTRY INCUBATION CO LTD

Portable range hood

SUZHOU LIUYAOSI INFORMATION TECH CO LTD

Method and system for optical vector analysis

GSCHWEND HEINZ W

Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

HANGZHOU SANHUA RES INST CO LTD

Pipeline adapter

ABREO MELWYN

Pyridyl derivatives and their use as therapeutic agents

XDCEXPLORER SHANGHAI CO LTD

Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof

AFFILIATED HOSPITAL QINGDAO UNIV

Dosimetry assessment method and system for organ at risk in esophageal radiotherapy plan